Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4

Qureshi, Omar S., Zheng, Yong, Nakamura, Kyoko, Attridge, Kesley, Manzotti, Claire, Schmidt, Emily M., Baker, Jennifer, Jeffery, Louisa E., Kaur, Satdip, Briggs, Zoe, Hou, Tie Z., Futter, Clare E., Anderson, Graham, Walker, Lucy S.K., Sansom, David M.·2011·Science

DOI 10.1126/science.1202947

Cited by (1,001)

Items 601–700 of 1,001

Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients
Michela Cangemi, Barbara Montico, Damiana Antonia Faè, Agostino Steffan, Riccardo Dolcetti · 2019 · Frontiers in Oncology
Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf
Fantini, Massimo Claudio, Favale, Agnese, Onali, Sara, Facciotti, Federica · 2020 · International Journal of Molecular Sciences
Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis
Ruoyu Li, Hui Li, Xiaoyan Yang, Huiru Hu, Peidong Liu, Hongbo Liu · 2022 · Frontiers in Immunology
Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies
Haiqing Jia, Lei Jiang, Xiaoyu Shen, Huinan Ye, Xinguang Li, Liwei Zhang, Yanyan Hu, Dandan Song, Hui Jia, Zhe Wang · 2025 · Molecular Cancer
Ubiquitous LEA29Y Expression Blocks T Cell Co-Stimulation but Permits Sexual Reproduction in Genetically Modified Pigs
Andrea Bähr, Tobias Käser, Elisabeth Kemter, Wilhelm Gerner, Mayuko Kurome, Wiebke Baars, Nadja Herbach, Kirsti Witter, Annegret Wünsch, Stephanie C. Talker et al. · 2016 · PLoS ONE
Murine LRBA deficiency causes CTLA‐4 deficiency in Tregs without progression to immune dysregulation
Deborah Lilly Burnett, Ian A. Parish, Etienne Masle‐Farquhar, Robert Adrian Brink, Christopher Carl Goodnow · 2017 · Immunology and Cell Biology
Intrinsic cancer vaccination
Yoosoo Yang, Gi‐Hoon Nam, Gi Beom Kim, Yoon Kyoung Kim, In‐San Kim · 2019 · Advanced Drug Delivery Reviews
Multiple Sclerosis: Lipids, Lymphocytes, and Vitamin D
Colleen E. Hayes, James Mukasa Ntambi · 2020 · Immunometabolism
Trans-endocytosis elicited by nectins transfers cytoplasmic cargo, including infectious material, between cells
Alex R. Generous, Oliver J. Harrison, Regina B. Troyanovsky, Mathieu Mateo, Chanakha K. Navaratnarajah, Ryan C. Donohue, Christian Karl Pfaller, Olga Alekhina, Alina P. Sergeeva, Indrajyoti Indra et al. · 2019 · Journal of Cell Science
Regulatory Cells and Transplantation Tolerance
Stephen Paul Cobbold, Herman Waldmann · 2013 · Cold Spring Harbor Perspectives in Medicine
Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment
Lili Xu, Pengtao Xu, Jingsong Wang, Hui Ji, Lin Zhang, Zhihua Tang · 2024 · European Journal of Pharmacology
CD28 and ITK signals regulate autoreactive T cell trafficking
Nitya Jain, Bing Miu, Jian‐kang Jiang, Karl Kai McKinstry, Amanda Prince, Susan L. Swain, Dale L. Greiner, Craig J. Thomas, Michael J. Sanderson, Leslie J. Berg et al. · 2013 · Nature Medicine
Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
Md. Selim Ahmed, Yong‐Soo Bae · 2016 · Immune Network
Class II MHC–independent suppressive adhesion of dendritic cells by regulatory T cells in vivo
Jiacong Yan, Bo Liu, Yan Shi, Hai Qi · 2017 · The Journal of Experimental Medicine
Checkpoint Inhibitors: Applications for Autoimmunity
Anna S. Tocheva, Adam Mor · 2017 · Current Allergy and Asthma Reports
Checks and Balances in Autoimmune Vasculitis
Rebeca Hid Cadena, Wayel Habib Abdulahad, Geke A.P. Hospers, Thijs T. Wind, Annemieke M. H. Boots, Peter Heeringa, Elisabeth Brouwer · 2018 · Frontiers in Immunology
Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
Ruidi Jiao, Hui Luo, Wenbo Xu, Hong Ge · 2019 · OncoTargets and Therapy
Cross talk between human regulatory T cells and antigen‐presenting cells: Lessons for clinical applications
Christine M. Wardell, Katherine N. MacDonald, Megan K. Levings, Laura E. Cook · 2020 · European Journal of Immunology
A review on applications of abatacept in systemic rheumatic diseases
Min Liu, Yikai Yu, Shaoxian Hu · 2021 · International Immunopharmacology
Immune checkpoint inhibitors and reproductive failures
Zeyang Chen, Jinxia Huang, Joanne Y-H Kwak-Kim, Wenjuan Wang · 2023 · Journal of Reproductive Immunology
Targeting RNA N6-methyladenosine to synergize with immune checkpoint therapy
Xianyong Zhou, Chen Li, Tong Chen, Wenhao Li, Xiaolong Wang, Qifeng Yang · 2023 · Molecular Cancer
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru Seetharama Sastry, Salim Bougarn, Neha Gopinath, Evonne C. Chin-Smith, Yashi Sinha, Hesham Mohamed Korashy, Cristina Maccalli · 2023 · Advances in Cancer Biology - Metastasis
Molecular Insights for Optimizing T Cell Receptor Specificity Against Cancer
Michaël Hebeisen, Susanne G. Oberle, Danilo Presotto, Daniel E. Speiser, Dietmar Zehn, Nathalie Rufer · 2013 · Frontiers in Immunology
Lymphopenia and autoimmunity: A double-edged sword
Javier Merayo‐Chalico, Sandra Rajme‐López, Ana Barrera‐Vargas, Jorge Carlos Alcocer-Varela, Mariana Díaz‐Zamudio, Diana Gómez‐Martín · 2016 · Human Immunology
Regulatory T Cell Metabolism in the Hepatic Microenvironment
Rebecca E. Wawman, Helen Bartlett, Ye Htun Oo · 2018 · Frontiers in Immunology
Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis
Hannah C. Jeffery, Manjit Kaur Braitch, Chris Bagnall, James A. Hodson, Louisa E. Jeffery, Rebecca E. Wawman, Lin Lee Wong, Jane Birtwistle, Helen Bartlett, Ansgar Wilhelm Lohse et al. · 2018 · Hepatology Communications
Flow Cytometry Contributions for the Diagnosis and Immunopathological Characterization of Primary Immunodeficiency Diseases With Immune Dysregulation
Otávio Cabral-Marques, Lena F. Schimke, Edgar Borges de Oliveira, Nadia El Khawanky, Rodrigo Nalio Ramos, Basel K. al-Ramadi, Gesmar Rodrigues Silva Segundo, Hans D. Ochs, Antônio Condino‐Neto · 2019 · Frontiers in Immunology
Biphenyl-based small molecule inhibitors: Novel cancer immunotherapeutic agents targeting PD-1/PD-L1 interaction
Pujan Sasmal, Sajeev Kumar Babasahib, B. R. Prashantha Kumar, Nulgumnalli Manjunathaiah Raghavendra · 2022 · Bioorganic & Medicinal Chemistry
Generating functionally stable and antigen-specific T reg cells from effector T cells for cell therapy of inflammatory diseases
Norihisa Mikami, Ryoji Kawakami, Atsushi Sugimoto, Masaya Arai, Shimon Sakaguchi · 2025 · Science Translational Medicine
Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
Angharad Lloyd, Owen N. Vickery, Bruno Laugel · 2013 · Frontiers in Immunology
Regulatory T cells and control of the germinal centre response
Ine Vanderleyden, Michelle A. Linterman, Kenneth G. C. Smith · 2014 · Arthritis Research & Therapy
Restoring Regulatory T Cells in Type 1 Diabetes
Allyson L. Spence, Qizhi Tang · 2016 · Current Diabetes Reports
Regulatory T-Cell Therapy for Graft-versus-host Disease.
Jessica Lauren Heinrichs, David A Bastian, Anandharaman Veerapathran, Claudio Anasetti, Brain Betts, Xue‐Zhong Yu · 2016 · PubMed
Targeting Immune Checkpoints in Lung Cancer: Current Landscape and Future Prospects
Long Long, Chen Zhao, Ozarina Muqimova, Xianda Zhao, Jing Liang Yang, Honglei Chen · 2019 · Clinical Drug Investigation
miR-181a/b-1 controls thymic selection of Treg cells and tunes their suppressive capacity
Marcin Łyszkiewicz, Samantha J. Winter, Katrin Witzlau, Lisa Föhse, Rebecca J. Brownlie, Jacek Puchałka, Nikita A. Verheyden, Heike Kunze‐Schumacher, Esther Imelmann, Jonas Blume et al. · 2019 · PLoS Biology
Phosphoinositide 3‐kinase δ is a regulatory T‐cell target in cancer immunotherapy
Ee Lyn Lim, Klaus Okkenhaug · 2019 · Immunology
Expression of costimulatory and inhibitory receptors in FoxP3+ regulatory T cells within the tumor microenvironment: Implications for combination immunotherapy approaches
Aras Toker, Pamela S. Ohashi · 2019 · Advances in cancer research
Low expressions of PD-L1 and CTLA-4 by induced CD4+CD25+ Foxp3+ Tregs in patients with SLE and their correlation with the disease activity
Ling Zhao, Xiaoyu Zhou, Xiaobin Zhou, Huijuan Wang, Lei Gu, Yao Ke, Miaojia Zhang, Xiaohui Ji, Xiaofan Yang · 2020 · Cytokine
Unraveling the Role of Immune Checkpoints in Leishmaniasis
Rafael de Freitas e Silva, Esther von Stebut · 2021 · Frontiers in Immunology
Antibody-based cancer immunotherapy by targeting regulatory T cells
Quanxiao Li, Jun Lu, Jinyao Li, Baohong Zhang, Yan‐Ling Wu, Tianlei Ying · 2023 · Frontiers in Oncology
Foxp3+ Regulatory T-cells and IL-2: The Moirai of T-cell Fates?
Georg Gasteiger, Wolfgang Kastenmüller · 2012 · Frontiers in Immunology
Moving CTLA-4 from the trash to recycling
David Michael Sansom · 2015 · Science
The CTLA‐4 immune checkpoint protein regulates PD‐L1:PD‐1 interaction via transendocytosis of its ligand CD80
Alan Kennedy, Maximillian A Robinson, Claudia Hinze, Erin Waters, Cayman Williams, Neil Halliday, Simon J. Dovedi, David Michael Sansom · 2023 · The EMBO Journal
Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection
Isaac Rosado‐Sánchez, Manjurul Haque, Kevin Salim, Madeleine Speck, Vivian C. W. Fung, Dominic A. Boardman, Majid Mojibian, Giorgio Raimondi, Megan K. Levings · 2023 · JCI Insight
Combining RAS(ON) G12C-selective inhibitor with SHP2 inhibition sensitises lung tumours to immune checkpoint blockade
Panayiotis Anastasiou, Christopher Moore, Sareena Rana, Mona Tomaschko, Claire E. Pillsbury, Andrea de Castro, Jesse Boumelha, Edurne Mugarza, Sophie de Carné Trécesson, Ania Mikolajczak et al. · 2024 · Nature Communications
Myeloid-derived suppressor cells and their role in CTLA-4 blockade therapy
Yago Pico de Coaña, Giuseppe Valentino Masucci, Johan Hansson, Rolf W. Kiessling · 2014 · Cancer Immunology Immunotherapy
Thymus‐derived regulatory T cells restrain pro‐inflammatory Th1 responses by downregulating CD70 on dendritic cells
Maxime Dhainaut, Caroline Coquerelle, Sophie Uzureau, Julie Denoeud, Valérie Acolty, Guillaume Oldenhove, Adrien Galuppo, Tim D. Sparwasser, Kris Thielemans, Etienne Pays et al. · 2015 · The EMBO Journal
Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
Vinod Vijay Subhash, Mei Shi Yeo, Woei Loon Tan, Wei Peng Yong · 2015 · Journal of Immunology Research
The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses
Christoph C. Schwarz, Lukas Walter Unger, Benedikt Mahr, Klaus Aumayr, Heinz M. Regele, A.M. Farkas, Karin Hock, Nina Pilat, Thomas Wekerle · 2016 · American Journal of Transplantation
Immunotherapy in Ovarian Cancer
Weimin Wang, Janice Rebecca Liu, Weiping Zou · 2019 · Surgical Oncology Clinics of North America
Mechanism‐based treatment of cancer with immune checkpoint inhibitor therapies
Yara George Abdou, Manu Raj Pandey, Maithreyi Sarma, Shrunjal Shah, Jeffrey I. Baron, Marc S. Ernstoff · 2020 · British Journal of Clinical Pharmacology
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy
Lukas Amon, Lukas Hatscher, Lukas Heger, Diana Dudziak, Christian H.K. Lehmann · 2020 · Pharmaceutics
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
Seyed Hossein Kiaie, Mohammad‐Javad Sanaei, Masoud Heshmati, Zahra Asadzadeh, Iman Azimi, Saleh Hadidi, Reza Jafari, Behzad Baradaran · 2020 · Acta Pharmaceutica Sinica B
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
Christopher Tay, Yamin Qian, Shimon Sakaguchi · 2020 · Cancers
Incidence of Endocrine-Related Dysfunction in Patients Treated with New Immune Checkpoint Inhibitors: A Meta-Analysis and Comprehensive Review
Won Sang Yoo, Eu Jeong Ku, Eun Kyung Lee, Hwa Young Ahn · 2023 · Endocrinology and Metabolism
Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells
Bing Sun, Mingtao Liu, Meng Cui, Tao Li · 2019 · Immunology Letters
Uncoupling Therapeutic Efficacy from Immune-Related Adverse Events in Immune Checkpoint Blockade
Weilei Hu, Guosheng Wang, Yian Wang, Matthew John Riese, Ming You · 2020 · iScience
Sleep loss potentiates Th17‐cell pathogenicity and promotes autoimmune uveitis
Xiuxing Liu, Yuhan Su, Zhaohao Huang, Jianjie Lv, Chenyang Gu, Zhuang Li, Tianyu Tao, Yidan Liu, Qi Jiang, Runping Duan et al. · 2023 · Clinical and Translational Medicine
Regulatory T cells targeting a pathogenic MHC class II: Insulin peptide epitope postpone spontaneous autoimmune diabetes
Nyerhovwo Obarorakpor, Deep Patel, Reni Boyarov, Nansalmaa Amarsaikhan, Joseph Ray Cepeda, Doreen Eastes, Sylvia Robertson, Travis S. Johnson, Kai Yang, Qizhi Tang et al. · 2023 · Frontiers in Immunology
The Dual Role of Exosomes in the Tumor Microenvironment: From Pro‐Tumorigenic Signaling to Immune Modulation
Jiale Li, Jun Peng, Jiachong Wang, Zigui Chen · 2025 · Med Research
CD20+T cells have a predominantly Tc1 effector memory phenotype and are expanded in the ascites of patients with ovarian cancer
Marco de Bruyn, Valerie R. Wiersma, Maartje C.A. Wouters, Douwe Freerk Samplonius, Harry G. Klip, Wijnand Helfrich, Hans W. Nijman, Paul Eggleton, Edwin Bremer · 2015 · OncoImmunology
Immunological characterization of de novo and recall alloantibody suppression by CTLA4Ig in a mouse model of allosensitization
Irene K. Kim, Gordon D. Wu, N. Chai, Andrew S. Klein, Stanley C. Jordan · 2016 · Transplant Immunology
Therapeutic Development of Immune Checkpoint Inhibitors
Jilin Wang, Teddy Yang, Jie Xu · 2020 · Advances in experimental medicine and biology
Regulatory T Cells Maintain Selective Access to IL-2 and Immune Homeostasis despite Substantially Reduced CD25 Function
Erika T. Hayes, Cassidy E. Hagan, Liliane Khoryati, Marc A. Gavin, Daniel Campbell · 2020 · The Journal of Immunology
Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors
María‐Carlota Londoño, María Reig, on behalf of the RETOINMUNO Multidisciplinary Group · 2020 · Cancers
Braking Bad: Novel Mechanisms of CTLA-4 Inhibition of T Cell Responses
Scott M. Krummey, Mandy L. Ford · 2014 · American Journal of Transplantation
Exosome-Derived microRNA: Implications in Melanoma Progression, Diagnosis and Treatment
Qiang Ye, Zi Li, Yang Li, Yirong Li, Yan Zhang, Runlin Gui, Yue Cui, Qi Zhang, Qian Lü, Yuyan Xiong et al. · 2022 · Cancers
T Cell–Associated Immunotherapy for Hepatocellular Carcinoma
Weijie Ma, Long Wu, Fuling Zhou, Zhenfei Hong, Yufeng Yuan, Zhisu Liu · 2017 · Cellular Physiology and Biochemistry
Immunological phenotype of the murine Lrba knockout
Laura Y. Gámez-Díaz, Julika Neumann, Fiona I. Jäger, Michele Proietti, Felicitas Felber, Pauline Soulas-Sprauel, Lisa Perruzza, Fabio Grassi, Tamara Kögl, Peter Aichele et al. · 2017 · Immunology and Cell Biology
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells
Priscilla Do, Kyle A. Beckwith, Carolyn M. Cheney, Minh Tran, Larry P. Beaver, Brittany G. Griffin, Xiaokui Molly Mo, Yang Liu, Rosa Lapalombella, Erin K. Hertlein et al. · 2019 · The Journal of Immunology
Insights Into Mechanisms of Tumor and Immune System Interaction: Association With Wound Healing
А. V. Ponomarev, Irina Zh. Shubina · 2019 · Frontiers in Oncology
Peripheral tolerance by Treg via constraining OX40 signal in autoreactive T cells against desmoglein 3, a target antigen in pemphigus
Hisato Iriki, Hayato Takahashi, Naoko A. Wada, Hisashi Nomura, Miho Mukai, Aki Kamata, Hiromi Ito, Jun Yamagami, Takeshi Matsui, Yutaka Kurebayashi et al. · 2021 · Proceedings of the National Academy of Sciences
Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
Jiaqi Liang, Guoshu Bi, Guangyao Shan, Xing Jin, Yunyi Bian, Qun Wang · 2022 · Journal of Immunology Research
Therapeutic gene editing of T cells to correct CTLA-4 insufficiency
Thomas Andrew Fox, Benjamin Christopher Houghton, Lina Petersone, Erin Waters, Natalie M. Edner, Alexander J. McKenna, Olivier Preham, Claudia Hinze, Cayman Williams, Adriana S. Albuquerque et al. · 2022 · Science Translational Medicine
Recent Developments in Nanoparticle‐Based Photo‐Immunotherapy for Cancer Treatment
Zhongyuan Guo, Audrey T. Zhu, Ronnie H. Fang, Liangfang Zhang · 2023 · Small Methods
Rab8 Binding to Immune Cell-Specific Adaptor LAX Facilitates Formation of trans -Golgi Network-Proximal CTLA-4 Vesicles for Surface Expression
Matthew C. Banton, Kerry L. Inder, Elke Valk, Christopher E. Rudd, Helga Schneider · 2014 · Molecular and Cellular Biology
Biomechanics of T Cell Dysfunctions in Chronic Diseases
Sachith D. Gunasinghe, Newton G. Peres, Jesse Goyette, Katharina Gaus · 2021 · Frontiers in Immunology
Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Juanjuan Wang, Ningning Zhu, Lei Su, Rongcun Yang · 2023 · Cancer Letters
Transcriptional and Epigenetic Control of Regulatory T Cell Development
Yohko Kitagawa, James B. Wing, Shimon Sakaguchi · 2015 · Progress in molecular biology and translational science
CD28–CD80 Interactions Control Regulatory T Cell Motility and Immunological Synapse Formation
Timothy J. Thauland, Yoshinobu Koguchi, Michael Loran Dustin, David C. Parker · 2014 · The Journal of Immunology
Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials
Jessica S. Suwandi, Tatjana Nikolić, Bart O. Roep · 2017 · Frontiers in Immunology
Selective CD28 blockade attenuates CTLA-4–dependent CD8+ memory T cell effector function and prolongs graft survival
Danya Liu, Idelberto Raul Badell, Mandy L. Ford · 2018 · JCI Insight
The Central Role of Inflammation Associated with Checkpoint Inhibitor Treatments
Cristina Vâjâitu, Carmen Cristina DRAGHICI, Iulia Solomon, Cristina Victoria Lisievici, Alexandra Victoria Popa, Mihai Lupu, Constantin Căruntu, María Magdalena Constantin, Vlad Mihai Voiculescu · 2018 · Journal of Immunology Research
Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
Ibo Janssens, Nathalie Cools · 2020 · Cellular Immunology
Disrupting cancer angiogenesis and immune checkpoint networks for improved tumor immunity
Trevor S. Anderson, Amanda L. McCormick, Savanna L Piersall, Izuchukwu F. Okpalanwaka, Devin B. Lowe · 2022 · Seminars in Cancer Biology
Comparing the levels of CTLA‐4‐dependent biological defects in patients with LRBA deficiency and CTLA‐4 insufficiency
Mehmet Cihangir Çatak, Bengü Akçam, Sevgi Bilgiç Eltan, Royala Babayeva, İbrahim Serhat Karakuş, Gamze Akgun, Dilek Başer, Alper Bulutoğlu, Feyza Bayram, Nurhan Kasap et al. · 2022 · Allergy
The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection
Xu Zhan, Xue Xiang Jiang, Xueyu Dai, Bin Li · 2022 · Frontiers in Immunology
Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease
Keli Lee Hippen, Mehrdad Hefazi, Jemma H. Larson, Bruce R. Blazar · 2022 · Frontiers in Immunology
IL2RA+VSIG4+ tumor-associated macrophage is a key subpopulation of the immunosuppressive microenvironment in anaplastic thyroid cancer
Zongfu Pan, Lisha Bao, Xixuan Lu, Xiaoping Hu, Lu Li, Jinming Chen, Tiefeng Jin, Yiwen Zhang, Zhuo Tan, Ping Cheong Huang et al. · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Foxp3+ regulatory T cell therapy for tolerance in autoimmunity and solid organ transplantation
Jes M. Sanders, Shareni Jeyamogan, James M. Mathew, Joseph R. Leventhal · 2022 · Frontiers in Immunology
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
Marzieh Nikoo, Fatemeh Rabiee, Hossein Mohebbi, Negar Eghbalifard, Hamid Rajabi, Yalda Yazdani, Delaram Sakhaei, Mohammadreza Khosravifarsani, Reza Akhavan‐Sigari · 2023 · International Immunopharmacology
Complete clinical responses to cancer therapy caused by multiple divergent approaches: a repeating theme lost in translation
Brendon John Coventry, Ashdown · 2012 · Cancer Management and Research
Low regulatory T cell and high IL-17 mRNA expression in a mouse Graves’ disease model
Q. Yuan, Y. Zhao, Xiaoyun Zhu, Xingxing Liu · 2016 · Journal of Endocrinological Investigation
Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
Abdullah Younis, John G. Gribben · 2024 · Immuno
Regulatory T cells constrain T cells of shared specificity to enforce tolerance during infection
David E. J. Klawon, Nicole Pagane, Matthew T. Walker, Nicole K. Ganci, Christine H. Miller, Eric Gai, Donald M. Rodriguez, Bridgett K. Ryan-Payseur, Ryan K. Duncombe, Erin J. Adams et al. · 2025 · Science
Advances in engineering immune–tumor microenvironments on-a-chip: integrative microfluidic platforms for immunotherapy and drug discovery
Farnaz Dabbagh Moghaddam, Ali Anvar, Ehsan Ilkhani, Delara Dadgar, Maedeh Rafiee, Najmeh Ranjbaran, Pejman Mortazavi, Seyed Majid Ghoreishian, Yun Suk Huh, Pooyan Makvandi · 2025 · Molecular Cancer
High proportions of FOXP 3+ CD 25high T cells in neonates are positively associated with allergic sensitization later in childhood
Anna Strömbeck, Hardis Rabe, Anna‐Carin Lundell, Kerstin Andersson, Susanne Johansen, Ingegerd Adlerberth, Agnes E. Wold, Bill Hesselmar, Anna Rudin · 2014 · Clinical & Experimental Allergy
Variation in the CTLA4 3′UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes
V M de Jong, Arnaud Zaldumbide, Arno R. van der Slik, Sandra Laban, Bobby P.C. Koeleman, Bart O. Roep · 2015 · Genes and Immunity
Immune Checkpoint Blockade in Breast Cancer Therapy
Xia Bu, Yihui Yao, Xiaoyü Li · 2017 · Advances in experimental medicine and biology
Regulation of lung immunity by dendritic cells: Implications for asthma, chronic obstructive pulmonary disease and infectious disease
Marcus Peters, Karin Peters, Albrecht Bufe · 2019 · Innate Immunity